We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

“The target organ is hard to reach and biomarkers are not very good – we have mainly peripheral blood”

Another important lesson that we learned from all the intervention studies that have been done in people with type 1 diabetes, or at risk of type 1 diabetes, is that we are handicapped in this disease by the fact that the target organ is so hard to reach. Let’s look at rheumatoid arthritis. There, doctors can take biopsies or take punctures for fluid from the affected joints. In type 1 diabetes, we have to study the beta cell, that is so well hidden in the islets of Langerhans in the pancreas, and so we are desperately in need of biomarkers – biomarkers that can tell us what is happening in the pancreas. These biomarkers should be easily accessible – for instance biomarkers that occur in the blood, or in other tissues that can be easily accessed, because until now we have been very handicapped in, for instance, the imaging of the pancreas.
Play the audio to learn more